Patent · US Active

Non-invasive vagal nerve stimulation to treat disorders

US9399134B2 · kind B2 · utility

68Cited by
13References
49Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2014
Grant dateJul 26, 2016
Priority date
Expiry dateSep 23, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/36021
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Devices, systems and methods are disclosed for treating a variety of diseases and disorders that are primarily or at least partially driven by an imbalance in neurotransmitters in the brain, such as asthma, COPD, depression, anxiety, epilepsy, fibromyalgia, and the like. The technology involves the use of an energy source comprising magnetic and/or electrical energy that is transmitted non-invasively to, or in close proximity to, a selected nerve to temporarily stimulate, block and/or modulate the signals in the selected nerve such that neural pathways are activated to release inhibitory neurotransmitters in the patient's brain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.